MoneyWorks4Me

Global Longlife Hospital and Research Ltd (543520)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543520 NSE: Hospital & Healthcare Services | Small Cap | Global Longlife Hosp Share Price

₹13.68 -0.32 (-2.29%)

As on 28-Sep'26 16:59

Global Longlife Hospital and Research Ltd (543520)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543520 NSE: Hospital & Healthcare Services | Small Cap | Global Longlife Hosp Share Price

₹13.68 -0.32 (-2.29%)

As on 28-Sep'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹14 Cr.
Current Price
₹13.7
52-Week Low / High
₹9 / 27
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
98.6
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Steady versus 3-year growth rate
-100%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
22.88%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹10.5 Cr.
Face Value
₹10
All Time Low / High
₹9.00 / 141.10

Global Longlife Hospital and Research stock performance

Key Ratios
mw4me loader

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Global Longlife Hospital and Research Ltd a good quality company?
Global Longlife Hospital and Research Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Global Longlife Hospital and Research Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Global Longlife Hospital and Research Ltd vs industry peers?
Global Longlife Hospital and Research Ltd revenue CAGR is %, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Q.1 Promoter shareholding and pledge status of Global Longlife Hospital and Research Ltd?
Promoters hold 22.88% of the Global Longlife Hospital and Research Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Global Longlife Hospital and Research Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of -32.09% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Global Longlife Hospital and Research Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
ROCE % ⓘ12.1%3.7%13.5%29.4%6.7%-2.8%1.3%-4.2%-
Value Creation
Index ⓘ
-0.1-0.70.01.1-0.5-1.2-0.9-1.3-

Growth Parameters ⓘ

Sales ⓘ34.533.532.732.823.513.50.600
Sales YoY Gr.--2.9%-2.5%0.4%-28.4%-42.5%-95.7%-100%-
Adj EPS ⓘ2-1.22.95.21.7-2.1-2.7-1.6-1.6
YoY Gr.--163.1%NA77.1%-66.3%-217.8%NANA-
BVPS (₹) ⓘ0014.52058.922.623.821.621.6
Adj Net
Profit ⓘ
1.4-0.92.13.61.8-2.2-2.8-1.7-2
Cash Flow from Ops. ⓘ5.43.96.99.4-40.4-5.112.3-4.5-
Debt/CF from Ops. ⓘ562.50.9-0.2-2.500-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘNA-100%-100%-100%
Adj EPS ⓘNA-189.1%-198.1%NA
BVPSⓘNA8.3%-28.5%-9.3%
Share Price - - -32% -43.6%

Key Financial Parameters ⓘ

Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
Return on
Equity % ⓘ
11.1-7.216.323.64.5-4.8-10.7-6.8-7.6
Op. Profit
Mgn % ⓘ
19.510.116.625.317.3-1.8-717.10NAN
Net Profit
Mgn % ⓘ
4-2.66.3117.8-15.9-488.40-INF
Debt to
Equity ⓘ
2.22.11.70.60.20.500-
Working Cap
Days ⓘ
02061651254789426,57500
Cash Conv.
Cycle ⓘ
056334310312172200

Valuation of Global Longlife Hosp - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Financials

data not found
No data found!
data
No data found!
data
No data found!
data
No data found!

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Global Longlife Hospital and Research Ltd FAQs

The current trading price of Global Longlife Hosp on 28-Sep-2026 16:59 is ₹13.68.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 27-Sep-2026 the market cap of Global Longlife Hosp stood at ₹14.36 Cr

The latest P/E ratio of Global Longlife Hosp as of 27-Sep-2026 is 0.00.

The latest P/B ratio of Global Longlife Hosp as of 27-Sep-2026 is 0.63.

The 52-week high of Global Longlife Hosp is ₹26.73 and the 52-week low is ₹9.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Global Longlife Hosp is ₹0.00 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Global Longlife Hospital and Research Ltd is a below average quality company.

The key valuation ratios of Global Longlife Hospital and Research Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Global Longlife Hospital and Research Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Global Longlife Hospital and Research Ltd

Global Longlife Hospital and Research is known as a Multi Speciality Tertiary Care Hospital of Gujarat with many beds well equipped for Medical & Surgical Specialities. It provides platform to the doctors for treatment of their patients. The company has adopted the Standard Operating Procedures (SOPs) given by Ministry of Health & Family Welfare. Under the said SOPs every work function of its hospital is defined, every process is written down and every employee is trained in his/her duties as soon as he/she joins. Every equipment is maintained as per a predefined schedule. Every necessary license is obtained and renewed as required time to time. The company is certified by National Accreditation Board for Hospitals and Healthcare Providers (NABH Accredited) which is committed to support improvement of quality of healthcare service in its country for all strata of the population through various methodologies and tools to supplement the efforts of the providers of healthcare service and the requirements of the system at various levels. The main purpose of the company’s promoter is to serve the people, hence, the company is also following the same path for which it put its ethics above the all cost. Through the Mukhya Mantri Amrutum Yojana the company has served over 6,000 patients up till now.

The company has invested in, and have established a IT system both for clinical purposes as well as integrating systems and processes through HMS (Hospital Management System)which includes Central Registration module, Appointment, Barcode Generation, Case Paper Generation, OPD Billing, Procedure billing, IPD Registration, Advance & Refund, Due billing, TPA/Package Billing, User Management, Doctor Sharing, Software Security, Management Reports, Discharge Summary towards streamlining its clinical and administrative functions. It has adopted technology with a view to ensure quick transmission of disease data, subsequent analysis, and prompt disease management.

Business area of the company

The company provides health care services. The company offers Oncology, Ophthalmology, Cardiology, Dermatology, Gynecology, Spine Surgery, Plastic Surgery, Ultrasound, Microbiology, Dialysis, and Physiotherapy among other healthcare services. Global Longlife Hospital is certified by the National Accreditation Board for Hospitals and Healthcare Providers (NABH Accredited).

Major Events, Key Awards, Accreditations or Recognition

  • 2016: The company has received Leadership award of ‘Best emerging hospital of India’ by The Associated Chambers of Commerce and Industry of India.
  • 2018: The company has received ‘Global Achievers Awards For Health Excellence’ for outstanding achievement in Health and Social Services at 12th International Achievers on 'Global Business Opportunities', Dubai, UAE.
  • 2018: Certificate of Recognition as ‘Times Health Icon’ by Times Health Icon 2018 - A Times Group Company.
  • 2021: Certificate of Recognition as ‘Most Trusted Hospital’ by Times Healthcare Leaders Ahmedabad, 2021 - A Times Group Company.
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now